HIF1A and hepatocellular carcinoma: In the rabbit VX2 model by Guo et al. [146], the TAE with drug-free microspheres combined with intraarterial transfection of HIF-1α shRNA on HCC demonstrated superior anti-tumor efficacy compared to monotherapy.